Abstract |
T-cell immunoglobulin domain and mucin domain-3(TIM-3) is an activation induced inhibitory molecule involved in immune tolerance and is recently reported to induce T cell exhaustion which is mediated by carcinoembryonic antigen cell adhesion molecule 1( CEACAM1), another well-known molecule expressed on activated T cells and involved in T cell inhibition. To investigate the expression of TIM-3 and CEACAM1 on circulating CD8+ T cells and tumor infiltrating lymphocytes (TILs), 65 diagnosed colorectal cancer (CRC) patients and 38 healthy controls were enrolled in this study and the results showed that TIM-3 and CEACAM1 were both highly expressed on circulating CD8+ T cells in CRC patients and elevated on TILs compared with paraneoplastic T cells. Furthermore, TIM-3+ CEACAM1+ CD8+ T cells represented the most dysfunctional population with the least IFN-γ production. In addition, the expressions of TIM-3 and CEACAM1 were correlated with advanced stage and could be independent risk factors for CRC. We for the first time to our knowledge suggested that co-expression of TIM-3 and CEACAM1 can mediate T cell exhaustion and may be potential biomarkers for CRC prediction, highlighting the possibility of being immunotherapy targets.
|
Authors | Yang Zhang, Pengcheng Cai, Lei Li, Liang Shi, Panpan Chang, Tao Liang, Qianqian Yang, Yang Liu, Lin Wang, Lihua Hu |
Journal | International immunopharmacology
(Int Immunopharmacol)
Vol. 43
Pg. 210-218
(Feb 2017)
ISSN: 1878-1705 [Electronic] Netherlands |
PMID | 28038383
(Publication Type: Journal Article)
|
Copyright | Copyright © 2016 Elsevier B.V. All rights reserved. |
Chemical References |
- Antigens, CD
- Biomarkers, Tumor
- CD66 antigens
- Cell Adhesion Molecules
- HAVCR2 protein, human
- Hepatitis A Virus Cellular Receptor 2
- Interferon-gamma
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Antigens, CD
(metabolism)
- Biomarkers, Tumor
(metabolism)
- CD8-Positive T-Lymphocytes
(immunology)
- Cell Adhesion Molecules
(metabolism)
- Colorectal Neoplasms
(diagnosis, pathology)
- Female
- Hepatitis A Virus Cellular Receptor 2
(metabolism)
- Humans
- Interferon-gamma
(metabolism)
- Lymphocyte Activation
- Male
- Middle Aged
- Neoplasm Staging
- Prognosis
- Risk Factors
- Young Adult
|